Search
for
Sort by
Research 61–90 of 1000+
- Imaging prostate cancer (PCa) with [<sup>99m</sup> Tc(CO)<sub>3</sub> ]finasteride dithiocarbamate
- Hair, Hormones, and High-Risk Prostate Cancer
- Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia
- Effect of Cuscuta reflexa Extract in Mitigating Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation and Oxidative Stress
- Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori
- Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
- Oral administration of low-dose bisphenol A promotes proliferation of ventral prostate and upregulates prostaglandin D<sub>2</sub> synthase expression in adult rats
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men
- Efectos de la terapia combinada del D-004 y el Finasteride sobre la hiperplasia de próstata inducida por testosterona en ratas
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Update on medical management of benign prostatic hyperplasia
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis